Shuttle Pharmaceuticals Holdings (SHPH) Change in Acquisitions & Divestments (2023 - 2024)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Change in Acquisitions & Divestments of $1.7 million for Q3 2024, up 41.6% quarter-over-quarter from $1.2 million in Q2 2024.
Shuttle Pharmaceuticals Holdings (SHPH) Change in Acquisitions & Divestments (2023 - 2024) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Change in Acquisitions & Divestments history runs 2 years deep, the most recent figure standing at $1.7 million for Q3 2024.
- In Q3 2024, Change in Acquisitions & Divestments changed N/A year-over-year to $1.7 million; the TTM figure through Dec 2024 stood at $3.0 million (changed N/A YoY), while the FY2024 annual figure was $3.0 million, up 1475.0% from the prior year.
- Change in Acquisitions & Divestments for Q3 2024 stood at $1.7 million, up from $1.2 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $1.7 million in Q3 2024, with the low at $107895.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.87 Mn | 1.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1.66 Mn |
| Sep 30, 2024 | 1.66 Mn |
| Jun 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 1.18 Mn |
| Mar 31, 2024 | 120,000.00 |
| Mar 31, 2024 | 120,000.00 |
| Dec 31, 2023 | 107,895.00 |
| Dec 31, 2023 | 107,895.00 |